≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

Endpoint Browser

Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Q86
  • Cause of death: ICD-10 — Q86

2 out of 7 registries used, show all original rules.

45

4. Check minimum number of events

None

45

5. Include endpoints

None

45

6. Filter based on genotype QC (FinnGen only)

45

Control definitions (FinnGen only)

Control exclude
Q17_OTHER_CONGEN_MALFO

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Q8
Name in latin
Syndromata malformationum congenitarum e causis externis notis non alibi classificata

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1153 503 650
Only index persons 998 447 551
Unadjusted period prevalence (%)
Whole population 0.02 0.01 0.02
Only index persons 0.02 0.02 0.02
Median age at first event (years)
Whole population - 6.49 7.16
Only index persons 7.22 6.84 7.54

-FinnGen-

Key figures

All Female Male
Number of individuals 45 24 21
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 17.06 12.36 22.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
18
40
6.83
8.56
3.4
2.1
e6/l
0.6
1.3
—
9
19
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
16
41
5.50
6.36
3.8
2.1
e6/l
4.4
7.3
—
7
20
(3030467) Casts [#/volume] in Urine by Automated count
22
77
4.63
5.99
4.2
2.3
e6/l
0.2
0.3
0.14
17
57
(3042936) Bacteria identified in Isolate by Culture
12
29
5.28
4.98
2.2
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
16
55
3.96
4.26
6.8
3.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
27
134
3.54
4.12
9.4
5.1
umol/l
9.7
11.3
0.47
27
125
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
22
99
3.39
3.87
8.4
2.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
18
78
3.18
3.28
3.1
2.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
9
25
4.23
2.75
21.9
3.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
9
25
4.23
2.75
7.7
2.0
kpa
5.5
5.6
—
9
25
(3000850) Epithelial cells [#/volume] in Urine
15
64
3.02
2.75
2.9
2.0
e6/l
9.6
7.2
0.28
15
59
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
11
6.10
2.63
4.2
2.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
8
21
4.40
2.60
3.0
2.1
mmol/l
26.7
23.7
—
8
21
(3012544) pH of Venous blood
9
28
3.75
2.47
8.7
2.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
7
17
4.67
2.47
7.0
3.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
8
6.85
2.43
10.8
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
18
91
2.63
2.38
10.6
6.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
18
4.40
2.36
4.1
8.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
20
3.94
2.15
1.7
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
31
210
2.53
2.14
11.9
7.2
e9/l
4.4
3.6
1.20
24
185
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
10
5.47
2.13
1.6
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
5
10
5.47
2.13
37.4
3.8
%
94.4
94.5
—
5
10
(3002032) Base excess in Venous blood by calculation
8
27
3.37
2.05
9.6
2.4
mmol/l
3.7
1.5
—
8
16
(3033658) Prothrombin time (PT) actual/Normal
14
67
2.58
2.02
4.9
2.3
%
84.9
96.3
1.54
14
67
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
16
4.15
2.01
13.8
5.6
mmol/l
23.0
23.9
—
6
16
(3032080) INR in Blood by Coagulation assay
15
76
2.46
1.92
28.3
4.2
inr
1.6
1.1
—
6
27
(3001604) Monocytes [#/volume] in Blood
27
178
2.29
1.90
8.2
5.3
e9/l
0.6
0.5
0.69
20
164
(3006315) Basophils [#/volume] in Blood
27
179
2.27
1.86
8.2
5.2
e9/l
0.0
0.0
1.18
21
164
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
18
3.68
1.81
2.7
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
19
111
2.23
1.75
7.8
5.1
—
—
—
0
0
(3013512) EKG study
12
58
2.46
1.67
2.9
2.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
25
166
2.14
1.66
10.8
6.2
e9/l
0.0
0.0
0.00
16
135
(3036481) Cortisol [Moles/volume] in Serum or Plasma
7
26
2.99
1.66
2.9
2.2
nmol/l
449.6
422.3
—
7
26
(3022621) pH of Urine by Test strip
6
20
3.30
1.64
2.8
1.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
27
187
2.11
1.58
9.1
5.2
e9/l
0.2
0.2
0.50
22
171
(3019198) Lymphocytes [#/volume] in Blood
27
187
2.11
1.58
8.2
5.1
e9/l
1.9
2.1
0.40
22
173
(3025941) Bacteria identified in Stool by Culture
6
21
3.13
1.56
1.5
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
5
116
0.36
1.54
1.8
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
39
2.63
1.54
1.2
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
29
2.67
1.46
2.3
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
29
2.67
1.46
2.4
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
37
0.00
1.42
0.0
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
10
48
2.39
1.40
2.5
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
37
301
2.29
1.37
20.1
8.2
ml/min/173m2
98.4
98.2
0.01
30
229
(3014576) Chloride [Moles/volume] in Serum or Plasma
5
18
2.99
1.32
48.6
4.8
mmol/l
91.6
104.4
—
5
18
(3037467) Urinalysis macro (dipstick) panel - Urine
30
226
1.98
1.29
7.3
4.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
6
25
2.61
1.29
1.8
2.3
g/l
9.8
10.1
—
6
25
(3026008) Bacteria identified in Urine by Culture
15
90
2.00
1.24
4.7
2.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
33
0.00
1.22
0.0
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
20
2.68
1.18
1.4
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
12
68
2.04
1.14
2.3
1.5
%
1.5
1.3
0.56
12
62
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
13
79
1.91
1.02
3.7
2.4
u/l
49.0
55.5
0.89
13
72
(3044640) Blood type and Crossmatch panel - Blood
14
88
1.86
0.99
3.9
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
6
27
2.40
0.98
1.2
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
24
179
1.73
0.96
2.4
2.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
30
240
1.75
0.92
3.1
3.8
mm/h
11.5
8.2
0.41
25
224
(46235355) HIV 1 and 2 tests - Meaningful Use set
19
137
1.67
0.84
1.8
2.3
—
—
—
0
0
(3002256) Pathology report gross observation
0
25
0.00
0.82
0.0
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
25
0.00
0.82
0.0
1.7
—
286.9
—
0
8
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
5
24
2.21
0.77
8.0
4.3
u/l
244.0
211.4
—
5
24
(3011397) Hemoglobin [Presence] in Urine by Test strip
11
69
1.79
0.77
5.9
3.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
39
1.94
0.77
1.4
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
14
95
1.69
0.76
6.4
2.8
mmol/l
8.4
8.8
0.08
14
79
(1761868) Lipid panel - Serum or Plasma
8
120
0.60
0.67
3.5
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
29
1.81
0.66
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
36
318
1.66
0.65
24.0
9.6
%
13.5
13.2
0.56
36
311
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
5
30
1.75
0.63
2.6
2.0
%
22.4
28.0
—
5
30
(3003327) Ova and parasites identified in Stool by Light microscopy
0
21
0.00
0.62
0.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
36
1.77
0.59
1.5
2.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
38
1.67
0.57
2.0
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
6
39
1.62
0.55
1.3
1.2
—
—
—
0
0
(3015736) pH of Urine
17
131
1.48
0.53
7.1
2.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
11
77
1.57
0.51
1.7
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
20
160
1.45
0.51
9.8
4.1
estimate
0.0
0.0
—
5
35
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
10
69
1.58
0.49
3.8
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
14
105
1.48
0.49
1.4
1.4
g/l
2.0
2.0
—
7
62
(40761536) Microorganisms panel - Urine sediment
5
31
1.69
0.45
3.0
3.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
16
0.00
0.42
0.0
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
20
165
1.38
0.41
7.0
3.0
estimate
0.0
0.0
—
5
36
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
18
146
1.39
0.41
2.5
2.6
ug/l
42.4
59.6
0.73
18
139
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
30
328
0.74
0.32
3.3
3.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
15
122
1.34
0.32
1.6
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
18
152
1.31
0.30
9.3
3.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
14
114
1.33
0.30
1.7
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
19
164
1.27
0.26
7.1
2.9
estimate
0.0
0.0
—
5
36
(36660697) Celiac disease serology panel - Serum
5
38
1.35
0.24
1.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
41
1.25
0.23
1.6
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
32.0
—
0
11
(3004588) Protein electrophoresis panel - Serum or Plasma
0
10
0.00
0.21
0.0
7.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
47
1.32
0.21
1.5
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
33
308
1.27
0.21
5.0
3.4
mmol/l
2.7
2.8
0.27
28
285
(3000764) Benzodiazepines [Presence] in Urine
6
52
1.18
0.20
1.5
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
52
1.18
0.20
1.5
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
52
1.18
0.20
1.5
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
52
1.18
0.20
1.5
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
15
130
1.23
0.19
8.4
2.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
7
61
1.17
0.18
1.3
1.4
mg/l
1.9
0.6
—
7
39
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
13
114
1.20
0.14
2.1
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
60
0.81
0.09
3.2
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
5
63
0.77
0.09
2.4
2.7
ug/g
131.5
111.0
—
5
44
(40761511) CBC panel - Blood by Automated count
39
378
1.24
0.08
26.2
7.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
73
0.79
0.08
1.2
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
11
100
1.13
0.06
6.7
2.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
35
347
1.04
0.00
22.1
8.7
%
37.8
41.2
0.93
29
296
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
117
1.03
0.00
2.3
2.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
123
0.97
0.00
2.6
2.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
11
105
1.06
0.00
1.4
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
7
74
0.94
0.00
9.6
5.8
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
118.9
—
0
6
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
72
0.97
0.00
2.6
2.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
86
0.92
0.00
1.5
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
0.0
—
0
5
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
7.7
—
0
5
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
2.0
—
0
5
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
29.6
—
0
5
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
3.1
—
0
5
(3037756) Immunofixation for Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
0.0
—
0
5
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
6.4
—
0
5
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
0.0
—
0
5
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
2.7
—
0
5
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
4.2
—
1.1
—
0
5
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
38.9
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED – Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data